{"query": "What transcription factors drive an SCLC neuroendocrine phenotype"}
{"query": "Is there a relationship between Inflammatory and Non-neuroendocrine SCLC subtype"}
{"query": "Rank molecular targets that are most likely to interfere with the transition from neuroendocrine to non-neuroendocrine SCLC subtype"}
{"query": "Are there unique gene regulatory networks that drive treatment resistance in SCLC"}
{"query": "Elaborate on strategies that could inhibit phenotypic plasticity in SCLC"}
{"query": "List molecular pathways that promote the affinity of SCLC metastasis for brain"}
{"query": "What drives the sensitivity of SCLC tumors to chemotherapy"}
{"query": "What components of cigarette smoke are directly responsible for SCLC initiation"}
{"query": "Why does SCLC initiation require biallelic inactivation of both RB and TP53 gene products"}
{"query": "Make a list of mechanisms that inactivate RB and TP53 in SCLC, with relative frequencies"}
{"query": "Will MYC inhibition block SCLC plasticity, and if so, are there any precedents for that in other cancer types."}
{"query": "What is the cell of origin of SCLC"}
{"query": "Does COPD always precede SCLC initiation"}
{"query": "Why does SCLC only occur in a small percentage of heavy smokers"}
{"query": "What is the most sensitive and accurate test for early detection of SCLC"}
{"query": "Why does SCLC have a poor response to immunotherapy"}
{"query": "What are the predominant genetic mutations driving the onset and progression of small cell lung cancer (SCLC)?"}
{"query": "How do mutational events in TP53, RB1, and other tumor suppressor genes contribute to the initiation and evolution of SCLC?"}
{"query": "Are there lesser-known or novel driver mutations (e.g., CREBBP, EP300, TP73, SOX family, FGFR1, MYC) with significant functional impact in SCLC pathogenesis?"}
{"query": "Which molecular subtypes can be identified within SCLC based on genetic and transcriptomic profiling, and how do these subtypes correlate with clinical features and therapy response?"}
{"query": "How do different driver alterations (e.g., NOTCH pathway disruption, MYC amplification, ALK rearrangements) affect the phenotype and biology of SCLC subtypes?"}
